Dynavax Technologies Corp (DVAX)
11.79
+0.01
(+0.08%)
USD |
NASDAQ |
Nov 04, 16:00
11.79
0.00 (0.00%)
Pre-Market: 08:33
Dynavax Technologies Revenue (Quarterly): 73.80M for June 30, 2024
Revenue (Quarterly) Chart
Historical Revenue (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2024 | 73.80M |
| March 31, 2024 | 50.79M |
| December 31, 2023 | 55.60M |
| September 30, 2023 | 69.51M |
| June 30, 2023 | 60.25M |
| March 31, 2023 | 46.92M |
| December 31, 2022 | 184.49M |
| September 30, 2022 | 167.74M |
| June 30, 2022 | 256.46M |
| March 31, 2022 | 113.99M |
| December 31, 2021 | 195.07M |
| September 30, 2021 | 108.27M |
| June 30, 2021 | 52.77M |
| March 31, 2021 | 83.34M |
| December 31, 2020 | 19.55M |
| September 30, 2020 | 13.41M |
| June 30, 2020 | 2.668M |
| March 31, 2020 | 10.92M |
| December 31, 2019 | 10.57M |
| September 30, 2019 | 10.58M |
| June 30, 2019 | 8.301M |
| March 31, 2019 | 5.773M |
| December 31, 2018 | 5.318M |
| September 30, 2018 | 1.461M |
| June 30, 2018 | 1.254M |
| Date | Value |
|---|---|
| March 31, 2018 | 0.165M |
| December 31, 2017 | 0.021M |
| September 30, 2017 | 0.053M |
| June 30, 2017 | 0.105M |
| March 31, 2017 | 0.148M |
| December 31, 2016 | 7.292M |
| September 30, 2016 | 0.162M |
| June 30, 2016 | 2.647M |
| March 31, 2016 | 0.942M |
| December 31, 2015 | 0.685M |
| September 30, 2015 | 1.188M |
| June 30, 2015 | 1.55M |
| March 31, 2015 | 0.627M |
| December 31, 2014 | 2.277M |
| September 30, 2014 | 2.209M |
| June 30, 2014 | 3.048M |
| March 31, 2014 | 3.498M |
| December 31, 2013 | -2.291M |
| September 30, 2013 | 2.927M |
| June 30, 2013 | 3.392M |
| March 31, 2013 | 2.085M |
| December 31, 2012 | -2.133M |
| September 30, 2012 | 2.874M |
| June 30, 2012 | 2.684M |
| March 31, 2012 | 2.35M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (Quarterly) Range, Past 5 Years
2.668M
Minimum
Jun 2020
256.46M
Maximum
Jun 2022
82.95M
Average
60.25M
Median
Jun 2023
Revenue (Quarterly) Benchmarks
| Biogen Inc | 2.466B |
| Repligen Corp | 154.07M |
| West Pharmaceutical Services Inc | 746.90M |
| XOMA Royalty Corp | 5.654M |
| Xencor Inc | 16.96M |
Revenue (Quarterly) Related Metrics
| Net Income (Quarterly) | 11.39M |
| Total Expenses (Quarterly) | 68.60M |
| EPS Diluted (Quarterly) | 0.08 |
| Enterprise Value | 1.033B |
| Gross Profit Margin (Quarterly) | 83.76% |
| Profit Margin (Quarterly) | 15.43% |
| Earnings Yield | 0.93% |
| Normalized Earnings Yield | 0.8895 |